Literature DB >> 15795254

Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques.

Vida L Hodara1, M Cristina Velasquillo, Laura M Parodi, Luis D Giavedoni.   

Abstract

Human immunodeficiency virus infection is characterized by dysregulation of antigen-presenting cell function and defects in cell-mediated immunity. Recent evidence suggests that impaired ability of CD4+ T cells to upregulate the costimulatory molecule CD154 is at the core of this dysregulation. To test the hypothesis that increased expression of CD154 on infected CD4+ T cells could modulate immune function, we constructed a replication-competent simian immunodeficiency virus (SIV) vector that expressed CD154. We found that this recombinant vector directed the expression of CD154 on the surface of infected CD4+ T cells and that expression of CD154 resulted in activation of B cells present in the same cultures. Experimental infection of rhesus macaques resulted in very low viral loads for the CD154-expressing virus and the control virus, indicating that expression of CD154 did not result in increased viral replication. Analyses of the anti-SIV immune responses and the phenotype of lymphocytes in blood and lymphoid tissues showed changes that occurred during the acute phase of infection only in animals infected with the CD154-expressing SIV, but that became indistinguishable from those seen in animals infected with the control virus at later time points. We conclude that the level of expression of CD154 in itself is not responsible for affecting the immune response to an attenuated virus. Considering that the CD154-expressing SIV vector and the virus control did not carry an active nef gene, our results suggest that, in CD4+ T cells infected with wild-type virus, Nef is the viral factor that interferes with the immune mechanisms that regulate expression of CD154.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795254      PMCID: PMC1069524          DOI: 10.1128/JVI.79.8.4679-4690.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys.

Authors:  L Alexander; R S Veazey; S Czajak; M DeMaria; M Rosenzweig; A A Lackner; R C Desrosiers; V G Sasseville
Journal:  AIDS Res Hum Retroviruses       Date:  1999-01-01       Impact factor: 2.205

3.  Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.

Authors:  P di Marzio; R Mariani; R Lui; E K Thomas; N R Landau
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

4.  Recombinant human CD40 ligand inhibits simian immunodeficiency virus replication: a role for interleukin- 16.

Authors:  M E Lee; S Z Bucur; T W Gillespie; J W Adams; A T Barker; E K Thomas; J D Roback; C D Hillyer
Journal:  J Med Primatol       Date:  1999 Aug-Oct       Impact factor: 0.667

Review 5.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

6.  Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.

Authors:  L D Giavedoni; M C Velasquillo; L M Parodi; G B Hubbard; V L Hodara
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets.

Authors:  U Thienel; J Loike; M J Yellin
Journal:  Cell Immunol       Date:  1999-12-15       Impact factor: 4.868

Review 8.  The emerging role of CD40 ligand in HIV infection.

Authors:  R S Kornbluth
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

9.  Low levels of productive HIV infection in Langerhans cell-like dendritic cells differentiated in the presence of TGF-beta1 and increased viral replication with CD40 ligand-induced maturation.

Authors:  T Kawamura; M Qualbani; E K Thomas; J M Orenstein; A Blauvelt
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

10.  HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Authors:  L Morris; J M Binley; B A Clas; S Bonhoeffer; T P Astill; R Kost; A Hurley; Y Cao; M Markowitz; D D Ho; J P Moore
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  3 in total

1.  Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8+ B Cells Are Associated with Sterilizing Immunity Provided by a Live Attenuated SIV Vaccine.

Authors:  Vida L Hodara; Laura M Parodi; M Shannon Keckler; Luis D Giavedoni
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-17       Impact factor: 2.205

2.  Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation.

Authors:  Nahid Waleh; Steven Seidner; Donald McCurnin; Luis Giavedoni; Vida Hodara; Susan Goelz; Bao Mei Liu; Christine Roman; Ronald I Clyman
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

3.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.